e-learning
resources
Berlin 2001
Monday 24.09.2001
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heredity and smoking factor in relatives patients with chronic obstructive pulmonary disease - chronic obstructive bronchitis (I) and chronic nonobstructive bronchitis (II)
T. V. Ivtchik, G. I. Rasorenov, A. N. Kokosov, E. A. Kiseleva, N. E. Hodgaynce, L. N. Karlova, E. D. Iantchina, V. P. Molodtsova, N. G. Yakovleva, V. V. Lim (Saint-Petersburg, Russia)
Source:
Annual Congress 2001 - COPD
Session:
COPD
Session type:
Thematic Poster Session
Number:
1494
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. V. Ivtchik, G. I. Rasorenov, A. N. Kokosov, E. A. Kiseleva, N. E. Hodgaynce, L. N. Karlova, E. D. Iantchina, V. P. Molodtsova, N. G. Yakovleva, V. V. Lim (Saint-Petersburg, Russia). Heredity and smoking factor in relatives patients with chronic obstructive pulmonary disease - chronic obstructive bronchitis (I) and chronic nonobstructive bronchitis (II). Eur Respir J 2001; 16: Suppl. 31, 1494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Definition of risk development obstructive syndrome with patients chronic bronchitis (CB)
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
Prevalence of chronic rhinosinusitis in COPD stable patients
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
Source: Eur Respir J 2012; 40: 28-36
Year: 2012
Characteristics and comorbidities associated with pain in people with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Prevelance of anemia in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 608s
Year: 2004
Chronic obstructive pulmonary disease (COPD) – patient‘s perspective
Source: Eur Respir J 2007; 30: Suppl. 51, 168s
Year: 2007
Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept